XTL Biopharmaceuticals Ltd. (XTLB) — Dilution Risk Analysis
Current Snapshot
XTL Biopharmaceuticals Ltd. (XTLB) has a DilutionWatch score of 37/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 37/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 6-K 4, 3 2.
| Form | Filed | Accession |
|---|---|---|
| 6-K | 2026-06-30 | 0001213900-26-073813 |
| 6-K | 2026-06-29 | 0001213900-26-073158 |
| 6-K | 2026-05-07 | 0001213900-26-053067 |
| 6-K | 2026-04-29 | 0001213900-26-048875 |
| 3 | 2026-03-23 | 0001213900-26-032911 |
| 3 | 2026-03-23 | 0001213900-26-032909 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Three-year share count growth | 61.75% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 37/10) Source
- Share Count Growth (3-Year)
- 61.75% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.